dipyridamole has been researched along with Hemorrhage, Retinal in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayreh, SS | 1 |
| Podhajsky, PA | 1 |
| Zimmerman, MB | 1 |
| Zimmerman, SW | 1 |
| Bergin, JJ | 1 |
2 other studies available for dipyridamole and Hemorrhage, Retinal
| Article | Year |
|---|---|
Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cohort Studies; Dipyridamole; F | 2011 |
Heparin therapy for the renal disease of malignant hypertension.
Topics: Adult; Anemia, Hemolytic; Creatinine; Dipyridamole; Female; Guanethidine; Hematoma; Heparin; Humans; | 1974 |